➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Merck
Mallinckrodt
Express Scripts
Baxter
AstraZeneca

Last Updated: July 30, 2021

DrugPatentWatch Database Preview

Details for Patent: 9,676,525


Email this page to a colleague

« Back to Dashboard

Summary for Patent: 9,676,525
Title:Protective cap for a dispenser, and discharge device for discharging pharmaceutical and/or cosmetical liquids
Abstract: A protective cap for a dispenser for discharging liquids, wherein the dispenser has a liquid reservoir and an outlet opening through which the liquid is discharged into a surrounding atmosphere. The protective cap has an inner cap and an outer cap, the inner cap having a ventilation opening for communication between an interior of the protective cap and an external environment. Before use, the outer cap is mounted on the inner cap in a first position with the inner cap and the outer cap in sealing contact with each other and the ventilation opening is separated in an airtight and germproof manner from the environment, and the outer cap is movable relative to the inner cap from the first position to a second position in which the inner and outer caps are out of sealing contact with each other and the ventilation opening communicates with the environment.
Inventor(s): Greiner-Perth; Juergen (Gottmadingen, DE), Krampen; Gerald (Radolfzell, DE), Herz; Andi (Eigeltingen-Reute, DE), Shankar; Sai (Irvine, CA), Mallare; Antonio O. (Gardena, CA)
Assignee: APTAR RADOLFZELL GMBH (Radolfzell, DE)
Application Number:14/108,570
Patent Claim Types:
see list of patent claims
Use; Device;

Drugs Protected by US Patent 9,676,525

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Allergan RESTASIS MULTIDOSE cyclosporine EMULSION;OPHTHALMIC 050790-002 Oct 27, 2016 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial Y ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,676,525

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2014368816 ⤷  Free Forever Trial
Canada 2933062 ⤷  Free Forever Trial
China 105813950 ⤷  Free Forever Trial
Germany 102014201696 ⤷  Free Forever Trial
Denmark 3083431 ⤷  Free Forever Trial
European Patent Office 3083431 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Baxter
AstraZeneca
McKesson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.